vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Safehold Inc. (SAFE). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $97.9M, roughly 1.5× Safehold Inc.). Safehold Inc. runs the higher net margin — 28.5% vs 7.8%, a 20.7% gap on every dollar of revenue. On growth, Safehold Inc. posted the faster year-over-year revenue change (6.5% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 2.5%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
SAFE Investment Company Limited is a Chinese sovereign wealth fund based in Hong Kong.
NUTX vs SAFE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $97.9M |
| Net Profit | $11.8M | $27.9M |
| Gross Margin | 30.4% | 98.6% |
| Operating Margin | 20.4% | 27.4% |
| Net Margin | 7.8% | 28.5% |
| Revenue YoY | -41.1% | 6.5% |
| Net Profit YoY | -80.8% | 7.1% |
| EPS (diluted) | $2.34 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $97.9M | ||
| Q3 25 | $267.8M | $96.2M | ||
| Q2 25 | $244.0M | $93.8M | ||
| Q1 25 | $211.8M | $97.7M | ||
| Q4 24 | $257.6M | $91.9M | ||
| Q3 24 | $78.8M | $90.7M | ||
| Q2 24 | $76.1M | $89.9M | ||
| Q1 24 | $67.5M | $93.2M |
| Q4 25 | $11.8M | $27.9M | ||
| Q3 25 | $55.4M | $29.3M | ||
| Q2 25 | $-17.7M | $27.9M | ||
| Q1 25 | $21.2M | $29.4M | ||
| Q4 24 | $61.6M | $26.0M | ||
| Q3 24 | $-8.8M | $19.3M | ||
| Q2 24 | $-364.0K | $29.7M | ||
| Q1 24 | $-364.0K | $30.7M |
| Q4 25 | 30.4% | 98.6% | ||
| Q3 25 | 57.8% | 98.5% | ||
| Q2 25 | 51.2% | 99.1% | ||
| Q1 25 | 55.9% | 98.8% | ||
| Q4 24 | 55.0% | 98.8% | ||
| Q3 24 | 27.8% | 98.8% | ||
| Q2 24 | 29.7% | 98.8% | ||
| Q1 24 | 15.1% | 98.8% |
| Q4 25 | 20.4% | 27.4% | ||
| Q3 25 | 48.7% | 25.9% | ||
| Q2 25 | 13.8% | 25.5% | ||
| Q1 25 | 38.1% | 25.9% | ||
| Q4 24 | 44.4% | 24.6% | ||
| Q3 24 | 12.3% | 17.5% | ||
| Q2 24 | 7.0% | 26.7% | ||
| Q1 24 | 2.1% | 26.4% |
| Q4 25 | 7.8% | 28.5% | ||
| Q3 25 | 20.7% | 30.5% | ||
| Q2 25 | -7.3% | 29.8% | ||
| Q1 25 | 10.0% | 30.1% | ||
| Q4 24 | 23.9% | 28.3% | ||
| Q3 24 | -11.2% | 21.3% | ||
| Q2 24 | -0.5% | 33.0% | ||
| Q1 24 | -0.5% | 33.0% |
| Q4 25 | $2.34 | $0.38 | ||
| Q3 25 | $7.76 | $0.41 | ||
| Q2 25 | $-2.95 | $0.39 | ||
| Q1 25 | $3.33 | $0.41 | ||
| Q4 24 | $11.56 | $0.36 | ||
| Q3 24 | $-1.72 | $0.27 | ||
| Q2 24 | $-0.07 | $0.42 | ||
| Q1 24 | $-0.08 | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $21.7M |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $329.4M | $2.4B |
| Total Assets | $918.5M | $7.2B |
| Debt / EquityLower = less leverage | — | 1.90× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $21.7M | ||
| Q3 25 | $166.0M | $12.1M | ||
| Q2 25 | $96.7M | $13.9M | ||
| Q1 25 | $84.7M | $17.3M | ||
| Q4 24 | $40.6M | $8.3M | ||
| Q3 24 | $46.9M | $15.6M | ||
| Q2 24 | $40.8M | $13.4M | ||
| Q1 24 | $30.0M | $11.3M |
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.4B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.2B | ||
| Q1 24 | — | $4.1B |
| Q4 25 | $329.4M | $2.4B | ||
| Q3 25 | $317.2M | $2.4B | ||
| Q2 25 | $235.3M | $2.4B | ||
| Q1 25 | $176.9M | $2.4B | ||
| Q4 24 | $132.4M | $2.3B | ||
| Q3 24 | $60.4M | $2.3B | ||
| Q2 24 | $62.7M | $2.3B | ||
| Q1 24 | $63.0M | $2.3B |
| Q4 25 | $918.5M | $7.2B | ||
| Q3 25 | $964.5M | $7.1B | ||
| Q2 25 | $841.0M | $7.1B | ||
| Q1 25 | $761.9M | $6.9B | ||
| Q4 24 | $655.3M | $6.9B | ||
| Q3 24 | $438.5M | $6.8B | ||
| Q2 24 | $422.4M | $6.8B | ||
| Q1 24 | $404.3M | $6.7B |
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.89× | ||
| Q2 25 | — | 1.87× | ||
| Q1 25 | — | 1.85× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.88× | ||
| Q2 24 | — | 1.81× | ||
| Q1 24 | — | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $47.8M |
| Free Cash FlowOCF − Capex | $69.0M | — |
| FCF MarginFCF / Revenue | 45.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 5.95× | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $47.8M | ||
| Q3 25 | $99.5M | $-1.4M | ||
| Q2 25 | $27.3M | $28.0M | ||
| Q1 25 | $51.0M | $8.9M | ||
| Q4 24 | $54.0K | $37.9M | ||
| Q3 24 | $6.8M | $8.3M | ||
| Q2 24 | $13.3M | $24.8M | ||
| Q1 24 | $3.1M | $-3.1M |
| Q4 25 | $69.0M | — | ||
| Q3 25 | $99.2M | — | ||
| Q2 25 | $26.5M | — | ||
| Q1 25 | $50.9M | — | ||
| Q4 24 | $-341.0K | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $12.7M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 45.5% | — | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 10.9% | — | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.7% | — | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 5.95× | 1.72× | ||
| Q3 25 | 1.80× | -0.05× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | 2.40× | 0.30× | ||
| Q4 24 | 0.00× | 1.45× | ||
| Q3 24 | — | 0.43× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | -0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
SAFE
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $60.3M | 62% |
| Other | $33.7M | 34% |
| Stabilized Properties | $3.8M | 4% |
